4000% return with Teladoc Health, Inc
** long term investment **
On the above 10 day chart price action has corrected 97% since February 2021. A number of reasons now exist to be bullish, they include:
1) Price action and RSI resistance breakouts. Almost 4 years of resistance.
2) Regular positive divergence. Multiple oscillators print positive divergence over a 90 day period.
3) No stock splits.
4) 15% short interest. Who does that after a 97% correction?
5) The falling wedge forecast as measured from top and lower touch points calls for a macro move to the $400 area.
Is it possible price action corrects further after 97%? Sure, sellers love it.
Is it probable? No
Ww
Type: Investment
Risk: you decide
Timeframe for long: Ask me after it pops up 100%, you always do.
Return: 2000-4000%
Stop loss: will say elsewhere
On the above 10 day chart price action has corrected 97% since February 2021. A number of reasons now exist to be bullish, they include:
1) Price action and RSI resistance breakouts. Almost 4 years of resistance.
2) Regular positive divergence. Multiple oscillators print positive divergence over a 90 day period.
3) No stock splits.
4) 15% short interest. Who does that after a 97% correction?
5) The falling wedge forecast as measured from top and lower touch points calls for a macro move to the $400 area.
Is it possible price action corrects further after 97%? Sure, sellers love it.
Is it probable? No
Ww
Type: Investment
Risk: you decide
Timeframe for long: Ask me after it pops up 100%, you always do.
Return: 2000-4000%
Stop loss: will say elsewhere
BTC
bc1q2eckdzh0q8vsd7swcc8et6ze7s99khhxyl7zwy
Weblink: patreon.com/withoutworries
Allow 3-6 months on ideas. Not investment advice. DYOR
bc1q2eckdzh0q8vsd7swcc8et6ze7s99khhxyl7zwy
Weblink: patreon.com/withoutworries
Allow 3-6 months on ideas. Not investment advice. DYOR
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.